HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karl Ludwig Laugwitz Selected Research

Prasugrel Hydrochloride

12/2021Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial.
10/2021Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.
1/2021Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karl Ludwig Laugwitz Research Topics

Disease

4Acute Coronary Syndrome
12/2021 - 01/2021
2Heart Failure
01/2021 - 01/2020
2Fibrosis (Cirrhosis)
01/2021 - 01/2020
1Hemorrhage
10/2021
1Myocardial Infarction
10/2021
1Sepsis (Septicemia)
03/2021
1Reperfusion Injury
01/2020
1Infarction (Infarctions)
01/2020
1Hypertension (High Blood Pressure)
11/2015

Drug/Important Bio-Agent (IBA)

3Prasugrel HydrochlorideFDA Link
12/2021 - 01/2021
3TicagrelorIBA
12/2021 - 01/2021
1cadherin 5IBA
03/2021
1Proteins (Proteins, Gene)FDA Link
03/2021
1Cadherins (E-Cadherin)IBA
03/2021
1salicylhydroxamic acid (SHAM)IBA
01/2021
1AcidsIBA
01/2021
1AgrinIBA
01/2020

Therapy/Procedure

3Percutaneous Coronary Intervention
12/2021 - 01/2021
2Therapeutics
12/2021 - 01/2020
1Dual Anti-Platelet Therapy
12/2021
1Kidney Transplantation
11/2015